Brief: Hemostemix Signs Manufacturing Agreement With Aspire Health Science
22/02/2018 13:02
Feb 22 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX SIGNS MANUFACTURING AGREEMENT WITH ASPIRE
HEALTH
SCIENCE
* HEMOSTEMIX INC - PURSUANT TO DEAL, ASPIRE WILL BE
RESPONSIBLE
FOR MANUFACTURING OF CO'S LEAD PRODUCT ACP-01
* HEMOSTEMIX INC - MANUFACTURING AGREEMENT WITH ASPIRE
HEALTH HAS
AN INITIAL 1 YEAR TERM WITH PROVISIONS TO RENEW FOR ADDITIONAL 6
MONTH EXTENSIONS
Source text for Eikon: ID:nGNX28ZhrT
Further company coverage: HEM.V
(((Bangalore.newsroom@thomsonreuters.com);))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update